Bleomycin is an antitumour antibiotic that induces DNA strand breaks, leading to cancer cell apoptosis.
Recommended for:
Administered intravenously, intramuscularly, subcutaneously or intrapleurally under hospital supervision. Dose and schedule are tailored by an oncologist depending on cancer type and patient condition.
Contraindications:
Side Effects: